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The purpose of this article is to describe some ethical considerations that have arisen during the design and implementation of the health examina-
tion surveys conducted by the National Center for Health Statistics of the Centers for Disease Control and Prevention. Three major areas of concern
are discussed: sharing information from the study, banking and using banked tissue samples, and obligations for future testing of subjects. Specific
concerns of sharing information include: when to inform, whom to inform, maintaining confidentiality, and how to inform individuals. Specific con-
cerns of determining when sera will be banked and using banked samples include: depletion of samples for quality control, obtaining informed con-
sent for unanticipated uses, access by others, and requests for batches of samples. Finally, specific concerns regarding future testing of subjects
include: retesting for verification, retesting for interpretation, testing for different risk factors, and follow-up. Although existing surveys can provide
experience or even suggest guidelines, the uniqueness of any new survey will generate unique ethical problems, requiring the careful formulation of
unique solutions. - Environ Health Perspect 1 03(Suppl 3):75-80 (1995)
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Introduction
The purpose of this article is to provide a
perspective on the theoretical discussions of
ethical concerns of studies by discussing a
case study, the examination surveys con-
ducted at the National Center for Health
Statistics (NCHS) of the Centers for
Disease Control and Prevention. Of
course, the discussion of a case study will
not provide answers for other studies, but
it will illustrate the need for discussions
focused on ethical issues during the devel-
opment of research protocols. Also, the
description of situations that have arisen in
the NCHS experience may broaden the
perspective of investigators and make them
sensitive to potential new issues.
This article will not be an exhaustive
discussion of issues that have been con-
fronted by NCHS examination surveys.
Rather, three major concerns will be
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addressed: sharing information from the
study, specimen banking and using banked
tissue samples, and obligations for future
testing of subjects.
Survey Description
The National Center for Health Statistics
is one of the major federal statistical orga-
nizations. It has legislative authority to col-
lect statistics on the extent and nature of
illness and disability in the United States
(including life expectancy, the incidence
and prevalence of acute and chronic illness
and disability, and infant and maternal
mortality and morbidity); determinants of
health; health resources; use of health care
resources (including use of ambulatory ser-
vices, hospital care, nursing homes, and
other long-term care facilities); health care
costs and financing; and family formation,
growth, and dissolution (1). In summary,
NCHS has the mandate to describe the
health and health experience of the
American public. This is in contrast to
other agencies that target data collection on
individuals with certain health conditions
or diseases or study the clinical experience
of patients.
NCHS carries out its mission through
the conduct of many annual, periodic, and
longitudinal data systems and surveys.
Information is collected from vital records,
administrative records, interviews, and
examinations. The Center also maintains
an inventory of health facilities. The focus
of the discussion in this article is on the
examination surveys.
The National Health and Nutrition
Examination Surveys (NHANES) are
designed to periodically assess the health
and nutritional status of adults and chil-
dren in the United States through inter-
views and direct physical examinations.
The detailed interview includes demo-
graphic, socioeconomic, dietary, and
health-related questions. The examination
component consists of medical and dental
examinations, physiologic measurements,
and laboratory tests administered by
trained medical personnel in mobile exami-
nation centers. Individuals are identified
for participation in the surveys based on
census information, such that the resulting
study population is representative of the
age, race, and sex distribution of the
United States. A complex, stratified sam-
pling design is used.
In addition to the NHANES, a similar
survey was performed in the early 1980s
that targeted Hispanic populations in the
United States. This survey is referred to as
the Hispanic Health and Nutrition Exami-
nation Survey (HHANES). Collectively,
the examination surveys will be referred to
as HANES in the following text.
To understand the ethical issues that
will be discussed below, it is helpful to
understand the procedures of the survey.
As noted, households and individuals
within households are selected by the
Bureau of Census to reflect the national
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and regional age, race, and sex distribution
of the noninstitutionalized civilian
American public. In various surveys, spe-
cial populations, such as low income or
minority populations, have been empha-
sized using stratified sampling. Household
interviews are conducted and selected indi-
viduals from the household are invited to
undergo a detailed physical examination in
a mobile examination center (MEC). The
examination is an extensive process con-
ducted by a survey team consisting of a
physician, dentist, medical and health tech-
nicians, and dietary and health interview-
ers. All testing equipment is contained in
the MEC. In recent surveys, elderly and
disabled subjects who were not able to
come to the MEC could receive a partial
examination in the home. The interviewers
and examination trailers travel together to
locations determined through the multi-
stage, stratified sampling procedures.
As part of the physiologic assessments,
HANES collects samples of blood. The
blood is collected in a variety of vacutainer
tubes so that samples are available as whole
blood and serum; where appropriate, a
variety of anticoagulant chemicals are used.
Each of these samples is used for specific
determinations and sufficient samples are
collected so that repeat determinations can
be performed. However, after processing
by the laboratories, residual amounts of
these samples are sometimes available.
These samples have been collected from
the laboratories participating in the
HHANES and NHANES III and placed
in sera storage banks. The amounts of tis-
sue available vary considerably between
subjects.
The HANES program seeks advice on
ethical issues from an Institutional Review
Board, consisting of researchers from other
programs in NCHS and from nongovern-
ment institutions, in addition to medical
professionals and lay individuals. HANES
staff also occasionally seeks input from
other institutional review boards, such as
the board advising the National Institutes
of Health, to obtain a broader consensus
on some issues. All of the boards follow
advice from such federal and internation-
ally recognized deliberations as for
instance, the Privacy Act of 1974, confi-
dentiality considerations of the Public
Health Service Act (section 308D), and the
Belmont Commission's report (2).
Sharing Information
Several questions revolve around sharing
information from a study, including when
to inform, whom to inform, how to
inform, and maintaining confidentiality of
the information.
When to Inforn
On the surface, it might appear that the
answer to the issue "when to inform" is
"always." But that is not strictly true.
Consider a situation when either the infor-
mation is uninformative or the subject can-
not act on the information. In such a
situation, it is not clear whether it is appro-
priate to inform the subject and, therefore,
possibly engender concern. Certainly,
information should be shared when the
health status of the subject is known to be
at risk. In the HANES program, there
are three levels of need for information
sharing.
The most urgent level of need is when
an emergency arises in the MEC. In those
instances, transportation is immediately
arranged for the subject to the appropriate
health care facility or social services unit
and information regarding the health status
and testing results are given to the subject
to transmit to the appropriate personnel at
the receiving facility.
For a majority of the laboratory and
examination assessments preformed as part
of the HANES, standard interpretations of
the findings exist. For these assessments,
there is general agreement regarding
threshold or reporting levels. Conse-
quently, these findings are shared with the
subject. When the findings are abnormal, a
Rapid Reporting System is used to contact
the subject as early as possible after the
findings are noted. The subject is given
information on possible next steps she or
he might pursue to obtain further evalua-
tion of the findings and their implications.
For those subjects whose findings were in
the normative range, the subjects are also
informed of the results, but not as rapidly
as those with abnormal findings.
However, for some assessments per-
formed as part of the HANES, there are no
clear interpretations of the findings or
agreed-upon critical levels. In such cases, it
is difficult to interpret the findings to the
subject. Such an assessment might be
included in the HANES because of
research needs or the need to determine the
distribution in the general population. For
instance, when lead was originally being
assessed in tap water as part ofNHANES I
(1971-1975), there were no clear guide-
lines as to reportable levels. Similarly, the
implications of the presence of prostate-
specific antigen, considered but not
included in NIANES III, are unclear. The
approach HANES has taken is to report to
subjects the findings for clinically accepted
assessments, but not for research-based
findings. Burdening a survey with research-
based protocols can weigh a study down
with trying to address concerns of the sub-
jects regarding the interpretation of the
findings. It should be considered whether a
survey is the appropriate mechanism for
this kind of research.
Whom to Inform
Another ethical issue that will be a major
concern for surveys of exposure and risk
assessment is whom to inform.
Information from other data systems on
many sources of exposure are available to
the larger community, for instance, air pol-
lution or water pollution. In general,
HANES has not evaluated these forms of
public exposure. However, as noted above,
in NHANES I, tap water in the subject's
home was assessed for several possible con-
taminants. In fact, no violations of conta-
minant levels were found. However, the
survey was very concerned with whom to
inform should high levels be detected. In
many instances, the subject does not own
the home or is renting an apartment.
Should the homeowner or building man-
ager be informed? A further complication
is that the survey is conducted in many
states, and laws differ between states.
Therefore, it was conceivable that a level of
contaminant might be observed that was
not in violation of levels in the state in
which the subject resided, but would have
been in violation of levels in other States.
Would it have been the responsibility of
the survey to inform the subject that the
level detected would have been in violation
elsewhere? If a violation had been detected,
another complication arises in the determi-
nation ofwho is responsible to fix the situ-
ation. Is it the responsibility of the
homeowner or the water treatment facility?
These were issues which the survey did not
have the expertise to address. Fortunately,
the occasion never arose. However, this
means that researchers have never clearly
determined the extent to which these sur-
veys of personal health status and personal
risk behaviors are responsible for the evalu-
ation and interpretation of non-personal
risk factors. In future exposure and risk
surveys, these ethical issues must be
addressed.
Additional complications arise when
the exposures are based on self-reporting
by the subject, that is, when the exposures
are perceived exposures. For instance, in
the HHANES the subjects were asked if
they had been sprayed by chemicals while
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working in the agricultural fields. If such
an exposure were reported, should it be
reported and to whom? Several possibilities
exist. For instance, the local occupational
safety and health agency might be
informed or the employer might be
informed. There was concern that subjects
might lose their jobs if the officials or
employer were informed. To obtain unbi-
ased answers, it was explained to the sub-
jects that only they would receive the
individualized information from the study.
Another concern for the survey was the
family members who might also have been
exposed due to chemicals remaining on the
clothing of the worker. However, this
could not be verified. Another example of
self-reported exposure is a question
included in the NHANES III regarding
tobacco smoke exposure at work. In some
states there are laws requiring the employer
to provide a smoke-free environment.
When smoke exposure was reported by a
subject, was it the responsibility of the sur-
vey to inform the state or the employer?
Should the survey inform the subject that
these laws exist?
A new set of complications is arising as
surveys contemplate the use of DNA to
assess biologic markers. DNA is a very per-
sonal thing, but not a private thing. The
DNA of the individual is shared to varying
degrees with family members. The issue
that must be addressed arises in the situa-
tion when an adverse genetic result is
found. This situation has not yet arisen for
HANES because, at this time, DNA has
been stored, but not analyzed. If, however,
an adverse genetic result were found, what
are the responsibilities of the study to
inform family members of their possible
risk? In genetic counseling, the usual prac-
tice is to inform the patient and allow the
patient to determine whether and by
whom other family members will be
informed.
State and local governments often have
concerns regarding the findings of specific
assessments. For instance, many states have
laws regarding the reporting of blood lead
levels in children and in adults. NHANES
II, Hispanic HANES, and NHANES III
have all assessed lead in blood tissue sam-
ples. Because HANES is conducted
by a federal agency that is not subject to
state jurisdiction, it is the policy of
HANES to provide the test results to the
individual and, if these blood lead levels
were high, to provide information regard-
ing the agencies that are concerned with
the determination and followup of individ-
uals with high blood lead levels. It is then
the responsibility of the individual to
contact the agencies.
Indeed, the reporting of adverse (and
even normal) findings has been an evolving
procedure over the years, even for standard
clinical assessments. In earlier surveys,
HANES provided the clinical findings to
the physician of note. However, this
engendered several problems. In most
instances, the physician did not want the
information because it transferred some
implied liability to the physician. Often the
general practitioner did not know enough
to adequately interpret the findings. Then,
when the doctor sent the findings to spe-
cialists for their interpretation, the subjects
would receive bills. Sometimes the doctors
would feel it necessary to repeat the test
with their own laboratory, again generating
bills for the subject, often unnecessarily.
Sometimes the doctor would fear liability
for not having performed the assessment,
even if the subject was clinically asympto-
matic. As a result, the procedure of provid-
ing results to the physician was abandoned.
Today, results are provided to the subject,
with advice on possible next steps.
The family is often an interested party,
not only in the case of the DNA studies
noted above, but also when previously
unrecognized disease states or risk factors
are found. Obviously, the family would
share the burden of an ill family member.
However, it has been the policy ofHANES
to inform only the subject and allow the
subject to determine whether family mem-
bers should be informed. An exception to
this, of course, is when the subject is a
child.
Another situation that has arisen is
when the subject applies for insurance, sub-
sequent to participating in the study, and
does not want to undergo another exami-
nation. They may request that the findings
be sent to the insurance company. Again, it
is the HANES policy to send information
to the subject and then the subject
determines what should be done with that
information.
In summary, it is the policy of HANES
to inform only the subject, unless there is
an emergency situation and other authori-
ties need to be informed. This, however,
will not be the situation for all surveys.
Some surveys may be subject to local and
state laws. The determination of whom to
inform should be continually reevaluated
by study investigators.
Mainining Confidentiality
With regard to the issue of maintaining
confidentiality, for the HANES surveys,
the subject is the gate through which the
information must flow. With regard to the
production of computer data tapes, there
are standard regulations regarding the limi-
tation of personal identifiers, so the subject
is unlikely to be identified. This becomes a
complex issue, however, when the data are
linked to other data systems. It is conceiv-
able that enough detailed information
could be linked so that the probability of
identifying individuals is actually
improved. In those instances, the data need
to be made available in different formats.
For instance, data can be aggregated over
years or over geographic areas, with the
appropriate variables suppressed so that
identification is less likely. However, for a
multifaceted study that assesses the health
status of the subject and characterizes the
environment, as has been proposed by the
U.S. Environmental Protection Agency,
maintaining confidentiality will not be a
simple issue.
How to Inl;rm
It is of the utmost concern that the subject
never be labeled, i.e., never be "diagnosed,"
by a general health survey such as the
HANES studies. Rather, the subject is
informed that a finding is abnormal and
that medical advice and follow-up should
be sought. There are several reasons why a
diagnosis is not used. First, there may be
extenuating circumstances unknown to the
MEC staff that would have led to this find-
ing. Second, additional tests may be
required to determine the diagnostic status
of the individual. Third, "diagnoses" may
be misunderstood by third parties, such as
insurance companies. An interesting, but
disturbing, future situation might arise if
insurance companies start using genotype
information as if the genotypes were "diag-
noses" rather than risk factors. In most
instances, the genotype does not confer an
inevitable health status on the subject, but
rather imparts information regarding the
risk for a subject to have an altered health
state. In that sense, therefore, the genotype
is a risk factor, not a diagnosis.
The ability to provide counseling for
the subjects is limited in the HANES pro-
gram. The individual is sent a letter in
which great care is taken to explain the
potential ramifications of findings in lan-
guage that might be understandable to the
lay reader. Telephone numbers are avail-
able for the subject to call staff, including
medical officers, and ask questions. In
addition, when appropriate, the letter pro-
vides information on agencies and tele-
phone numbers where the subject can
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follow up on the finding. However, by the
time this information is available and sent
to the subject, the MEC has moved to
another city, often another region of the
country. Therefore, there is no opportunity
to speak face to face with the subject.
Because extensive counseling is not possi-
ble, clinically meaningful and interpretable
findings, rather than research-driven find-
ings, are shared with the subject. The sub-
ject has a better chance of obtaining
additional counseling and information
regarding the clinically meaningful findings
than research-based findings.
The issue of what to share and how to
share information with the subject should
be a major issue for any survey and will be
driven, in part, by the study's purpose. If a
survey obtains information for which the
consequences are largely unknown, it
would be well to consider how the subject
would benefit from the survey. It is impor-
tant for researchers and public health offi-
cials to provide subjects with some
immediately useful information in
exchange for their participation.
Banking and Using Banked
Tissue Samples
A central focus of this conference was tissue
banking. However, the banking of tissues is
not always the primary objective of a study.
Therefore, determining when sera are avail-
able for specimen banking and using those
banked tissue samples can be an ethical
concern for such a study. Four aspects of
this concern are discussed here: the deple-
tion of samples for quality control studies,
obtaining general informed consent, access
by others, and requests for batches of
samples.
Quality Control
The issue of depleting stores of banked
samples for quality control purposes is a
simple one for HANES-there are no
"surplus" sera until the whole protocol is
completed and quality information
obtained. It is a tacit agreement of the
HANES program with the subjects that the
laboratory analyses will be performed with
appropriate quality control. HANES gener-
ally obtains enough tissue to conduct the
quality control assessments and repeat
assessments that are required (also see the
Survey Description section). However, if
additional, multiple tests were required to
obtain quality information and, hence,
deplete the sera, the multiple tests would
be performed and the sera depleted. Only
after quality data have been obtained on all
the assessments would sera be declared
surplus and then stored. Requests for use of
the sera are reviewed at that time. In sum-
mary, quality control of all tests is the pri-
mary objective of the HANES. Banking of
remaining tissue samples has not been a
primary focus of the surveys.
Informed Consent
Obtaining informed consent for unantici-
pated uses is a difficult issue. Although
there are general phrases included in most
informed consent forms, the extent to
which these capture and the subjects
understand the possibilities and ramifica-
tions is often unknown. Often we, as
researchers, just wave our hands and say,
"We have the appropriate phrases in the
consent form," without careful considera-
tions of what the subject does, or should,
understand. An example of misunderstand-
ing that can arise is the following. In one
instance, the HANES sera were tested for
indications of exposure to a sexually trans-
mitted disease. Several individuals were
found to be positive, even after repeated
testing of the samples. One individual who
was found to be positive was a lady who
expressed shock and dismay and claimed
that she certainly would never have put
herself in a position to make it possible for
such a thing to happen. She did not under-
stand the possibilities of future testing of
her sera. In NHANES III, testing of
human immunodeficiency virus (HIV) and
drug substances are done anonymously.
The decision to perform these tests anony-
mously was based on a number of consid-
erations, including the inability of the
survey to provide counseling and the possi-
bility that subjects would refuse to partici-
pate in this testing, given the current
cultural context.
Another issue of informed consent is to
what extent the study should save the sera
for future, perhaps more sensitive and
accurate, laboratory testing and to what
extent the subject should be informed of
this possibility. In some university-based
programs, subjects have said that they gave
blood because they knew the investigators
were on the forefront of research and, if a
new procedure became available, the
researchers would be likely to perform the
test before their family doctor would. The
implication was that, if anything abnormal
were found, the investigators would tell the
research subject right away. These subjects
did not understand that even if new proce-
dures were used, because these new proce-
dures are largely untested, the implication
of the findings is usually unclear. Such
additional testing cannot be guaranteed by
a general health survey. In fact, new labora-
tory procedures are sometimes used on the
sera in the tissue bank, but because tissues
are not available on all subjects, the testing
of any one subject cannot be guaranteed.
Acce to Bamked Samples
The HANES studies are conducted with
the understanding that HANES "owns"
the samples. Over the years, HANES has
had a number of unusual requests for uses
of the banked samples. There are many
possible requests that HANES has not
received but that should be considered by
investigators. Samples might be requested,
following the death of the subject because
the sample was needed to resolve a medical
issue regarding conditions existing before
the death. Private industries or economi-
cally self-interested groups, in addition to
university-based researchers, might request
batches of samples to run special research
protocols. In fact, all requests are evaluated
regardless of the source of the request. The
requests are evaluated for scientific merit,
including the appropriateness of the survey
to answer the question of the investigator,
and availability of surplus sera. If the
research protocol is found to be appropri-
ate, samples are provided to the researchers
without personal identifiers.
Family members might request aliquots
of surplus sera. This type of request could
happen with any tissue samples, but inter-
esting new problems arise when DNA (or
white blood cells) are being stored. Unlike
most other analyses, the subject's DNA
genotype may have direct relevance for the
health of the requestor. For instance, if a
genetic defect is known to be present in the
family and the subject refused to be tested
as part of the family studies performed by
the genetic counselor, the family might
request that testing be performed on the
stored DNA. This situation has not arisen
for the HANES program, but ethical issues
regarding the use of DNA samples cur-
rently are being explored.
Requests for Batches
Requests for batches of samples to conduct
research are appropriate. HANES receives
more requests than they have sera to satisfy
them. Therefore, it is important that a
well-organized procedure be established to
determine whether requests for batches of
banked sera are appropriate. Reviews of
requests include external experts in addi-
tion to staff of the survey. The HANES
program uses the following criteria to
determine the acceptability of a request:
the public health significance, scientific
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merit, and practical utility of the assay; the
sampling scheme (random samples receive
high priority); characteristics of the speci-
men such as volume and impact of the
freeze-thaw cycles and protocols used dur-
ing storage; and number of assays per-
formed (multiple analytes determined from
one sample are given higher priority).
One aspect that might be considered in
a discussion of ethical issues is whether tar-
geting special population groups in excess
sera batch requests is appropriate when the
original study did not target that group. As
noted above, the HANES gives high prior-
ity to requests for random samples of the
survey because batch requests for targeted
special subgroup analyses decrease the
potential representativeness of the surplus
sera. That is, the use of parts of the
national sample for studies of special sub-
populations means that the reserved sera
for those subjects are depleted more
rapidly. Consequently, other requests for
random samples of the population might
not be possible to provide because of sera
missing from segments of the population.
The other disadvantage of targeting special
subpopulations for some research protocols
is that important research data are not
derived for the other segments of the popu-
lation. This, of course, has been one of the
arguments recently put forward regarding
health research and women.
There are, however, reasons for focus-
ing on subgroups in the population. For
instance, there is much concern in environ-
mental research for toxicant doses received
by children and by women during their
reproductive years. Doses received by the
elderly might be of equal concern, how-
ever, given their general lack of reserves
and, hence, greater sensitivity to environ-
mental insults. Exposures to men and mid-
dle-aged individuals should not be ignored.
Socially disadvantaged populations might
experience unusual exposures. Obviously,
one way to accommodate the focused study
on special populations is to design the sur-
vey to oversample these populations.
However, given limited resources and lack
of general clairvoyance with regard to
future issues, appropriately banked sera are
usually not available. The conflicting uses
of banked sera to address research ques-
tions for which the collection of sera was
not designed is an ethical issue that needs
to be addressed as we embark on more
large surveys. The effort involved in the
design, collection, and maintenance of
these surveys and banked tissues means
that we will get few opportunities to collect
such data. These well-designed tissue banks
become very valuable resources, but they
are valuable only to the extent to which
they are utilized. Blanket refusal to provide
sera except for very limited research designs
is not appropriate either.
Obligations for Future Testing
Finally, the obligation for future testing
takes several forms. A variety of situations
might be considered: retesting for verifica-
tion, retesting for interpretation of find-
ings, testing of different risk factors, and
follow-up.
Retesting for Verification
The HANES program tries to collect suffi-
cient samples on the initial contact to have
tissue samples available for retesting for
verification, should that be necessary.
Hence, for HANES, the survey is con-
ducted with the eye towards obtaining tis-
sue samples only once from the subject.
Retesting selected subjects for verification
of test results is usually not possible
because by the time test results are available
the MEC has usually relocated.
Retesting for Interpretation
ofFinding
Retesting for interpretation of findings is a
different issue. Retesting for interpretation
is not necessarily the use of the same test at
a later date on the individual, although it
might be, as for instance, a second evalua-
tion for high blood pressure. Retesting for
interpretation might also involve the retest-
ing of the individual using different proce-
dures to assist in the interpretation of
findings from the initial tests. An example
is a recent request that HANES include
evaluation for prostate-specific antigen.
Although this was certainly possible with
the protocol in place, the interpretation of
the findings would require follow-up test-
ing using, for instance, ultrasonography.
That was not possible with the HANES
design and, hence, the antigen testing was
not included. Another example is the use
of findings from the urine microalbumin-
uria assessments to retest subjects for
glomerular filtration rates. With the
National Institutes of Health, a protocol
was attempted to provide glomerular filtra-
tion rate tests to selected subjects.
However, given the scattered locations of
subjects (NHANES III is going to approxi-
mately 30 states), it was impossible to pro-
vide these complicated tests at sites near
the subject's residence and maintain qual-
ity control over the tests as well as the
information provided to the subject by
these associated centers.
Consequently, the HANES program
has avoided the inclusion of assessments
that require subsequent testing of subjects.
In other studies, the possibility of retesting
might be quite appropriate. But for studies
in which retesting and supportive follow-
up are not a viable option, the selection of
tests to be included in the study should be
evaluated in light of the implications of
findings for the subjects and the burden,
either psychological or financial, that
might be placed on the subject.
Testing for Different Risk Factors
Another situation that requires retesting
is the identification after the initial study
has been completed of different risk fac-
tors. Often information on the different
risk factors would be nice to have for inter-
pretation of the study findings. The
NHANES I has a longitudinal component
and subsequent HANES have been
planned with the possibility of longitudinal
studies. One example of retesting for dif-
ferent risk factors is the collection of smok-
ing information during the first wave of
the NHANES I Epidemiologic Follow-up
Study. In that study, which was performed
an average of 10 years after the NHANES
I, investigators attempted to collect infor-
mation on the smoking status of the sub-
jects at the time of the initial NHANES I
examination. Smoking status had not been
collected on all individuals in the initial
examination. The HANES longitudinal
studies, at this time, are limited to ques-
tionnaire follow-up. The ability to perform
limited examinations is being evaluated.
The ability to retest at later dates for either
newly identified risk factors or subsequent
health status is an important capability.
Follow-up
As noted above, the HANES program has
incorporated a follow-up component
largely limited to questionnaire informa-
tion. Follow-up is generally conducted on
the whole study population at the same
time. A survey may become burdened if
more flexible follow-up procedures are
implemented. It should be remembered
that the American population is highly
mobile, and, after a couple years, many of
the subjects may have moved, making
follow-up of the entire cohort with other
than mailed questionnaires virtually impos-
sible. This means that the subsequent col-
lection of tissue samples is not possible.
Therefore, large tissue banks should be
designed to include single samples from
subjects. This will, of course, limit the
types of research that can be conducted.
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Possible nested designs might overcome
these limitations to some extent.
It is important that subjects understand
whether or not follow-up will be per-
formed as part of the study and that
they also understand the nature of the
follow-up.
Summary
When approaching ethical issues, it should
be kept in mind that the underlying tenet
that motivates individuals to allow us, as
strangers, to obtain biological samples from
them is trust. It is really remarkable that
you can go knock on a door and someone
will actually allow you to "use" him for,
say, half a day as a subject in a survey, be it
a government survey or other research-
based survey. That is a trust we must
honor. Hence, the commitment that we
must have to drive our decisions regarding
the use of those specimens and information
obtained therefrom should be justice. In
this case, the larger sense of the word
"justice" is meant, that is, open informa-
tion exchange, fairness, and confidentiality.
Having said that, it should be equally clear
that each study must be resolved within
itself. Certainly, existing surveys can pro-
vide experience or even suggest guidelines,
but the uniqueness of any new survey will
generate unique ethical problems, requir-
ing the careful formulation of unique
solutions.
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